Prelude
PreludeDx was founded with the goal of providing better decision-making tools to breast cancer patients and physicians. Founded in 2009 with technology licensed from the University of California San Francisco, PreludeDx has focused on developing breast cancer tools that will impact a patient’s treatment decision. Their mission is to provide tools that improve patient outcomes in breast cancer and reduce the overall cost burden to the healthcare system.
Domain
preludedx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$20.0M
Founded
2008
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Prelude use?+
We have not yet detected technologies for Prelude.
What industry is Prelude in?+
Prelude operates in the Biotechnology industry.
Where is Prelude based?+
Prelude is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026